DENSO Corporation (DNZOF)
USD 14.6
(0.0%)
USD 14.6
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 7144.73 Billion | 5515.51 Billion | 4936.72 Billion | 5153.47 Billion | 5362.77 Billion | 5362.77 Billion |
| Cost of Revenue | 5539.2 Billion | 4714.02 Billion | 4275.23 Billion | 4423.87 Billion | 4531.87 Billion | 4531.87 Billion |
| Gross Profit | 1605.52 Billion | 801.48 Billion | 661.48 Billion | 729.6 Billion | 830.9 Billion | 830.9 Billion |
| Operating Expenses | 709.35 Billion | 460.3 Billion | 506.37 Billion | 668.52 Billion | 514.7 Billion | 514.7 Billion |
| Selling, General and Administrative Expenses | 474.71 Billion | 460.44 Billion | 514.49 Billion | 668.5 Billion | 513.32 Billion | 513.32 Billion |
| Research and Development Expenses | 550.92 Billion | 521.61 Billion | 497.55 Billion | 492.01 Billion | 507.82 Billion | 497.41 Billion |
| Other Expenses | -310.46 Billion | -1.15 Billion | -6.95 Billion | -84.61 Billion | -207.82 Billion | -29.27 Billion |
| Cost and Expenses | 6769.94 Billion | 5174.33 Billion | 4781.61 Billion | 5092.39 Billion | 5046.57 Billion | 5046.57 Billion |
| Operating Income | 374.78 Billion | 341.17 Billion | 155.1 Billion | 61.07 Billion | 316.19 Billion | 316.19 Billion |
| Interest Expense | 22.24 Billion | 8.4 Billion | 7.33 Billion | 9.62 Billion | 12 Billion | 12 Billion |
| Income Tax Expense | 80.66 Billion | 96.05 Billion | 45.65 Billion | 5 Billion | 76.42 Billion | 76.42 Billion |
| Earnings before Tax | 419.37 Billion | 384.8 Billion | 193.75 Billion | 89.63 Billion | 356.03 Billion | 356.03 Billion |
| Net Income | 312.79 Billion | 314.63 Billion | 125.05 Billion | 68.09 Billion | 254.52 Billion | 254.52 Billion |
| Earnings Per Share Basic | 104.97 | 104.00 | 40.61 | 21.97 | 82.12 | 81.83 |
| Earnings Per Share Diluted | 104.97 | 104.00 | 40.61 | 21.97 | 82.12 | 81.83 |
| Weighted Average Shares Outstanding | 2.97 Billion | 3.02 Billion | 3.07 Billion | 3.09 Billion | 3.09 Billion | 3.11 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.97 Billion | 3.02 Billion | 3.07 Billion | 3.09 Billion | 3.09 Billion | 3.11 Billion |
| Gross Margin | 0.22 | 0.15 | 0.13 | 0.14 | 0.15 | 0.15 |
| EBIT Margin | 0.11 | 0.13 | 0.11 | 0.08 | 0.12 | 0.12 |
| Profit Margin | 0.04 | 0.06 | 0.03 | 0.01 | 0.05 | 0.05 |
| EBITDA | 756.04 Billion | 790.43 Billion | 701.5 Billion | 494.54 Billion | 377.95 Billion | 612.29 Billion |
| Earnings Before Tax Margin | 0.05 | 0.06 | 0.03 | 0.01 | 0.06 | 0.06 |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | 1789.84 Billion | 7144.73 Billion | 1841.39 Billion | 1605.1 Billion | 1415 Billion | 5515.51 Billion |
| Cost of Revenue | 1362.22 Billion | 5539.2 Billion | 1542.82 Billion | 1385.08 Billion | 1241.36 Billion | 4714.02 Billion |
| Gross Profit | 427.62 Billion | 1605.52 Billion | 298.57 Billion | 220.01 Billion | 173.64 Billion | 801.48 Billion |
| Operating Expenses | 287.26 Billion | 1230.73 Billion | 271.81 Billion | 128.24 Billion | 110 Billion | 460.3 Billion |
| Selling, General and Administrative Expenses | 128.07 Billion | - | 276.14 Billion | 125.05 Billion | 115.58 Billion | - |
| Research and Development Expenses | 147.06 Billion | - | 137.57 Billion | 133.44 Billion | 132.83 Billion | - |
| Other Expenses | -12.12 Billion | -205.1 Billion | -149.64 Billion | -30.21 Billion | -13.12 Billion | -1.15 Billion |
| Cost and Expenses | 1649.48 Billion | 6769.94 Billion | 1814.63 Billion | 1513.33 Billion | 1351.36 Billion | 5174.33 Billion |
| Operating Income | 140.36 Billion | 374.78 Billion | 26.75 Billion | 91.77 Billion | 63.64 Billion | 341.17 Billion |
| Interest Expense | 2.16 Billion | 22.24 Billion | 8.53 Billion | 2.24 Billion | 2.79 Billion | 8.4 Billion |
| Income Tax Expense | -1.25 Billion | 80.66 Billion | 19.85 Billion | 25.48 Billion | 28.65 Billion | 96.05 Billion |
| Earnings before Tax | 142.42 Billion | 419.37 Billion | 41.05 Billion | 88.08 Billion | 82.56 Billion | 384.8 Billion |
| Net Income | 137.16 Billion | 312.79 Billion | 6.69 Billion | 53.92 Billion | 51.87 Billion | 314.63 Billion |
| Earnings Per Share Basic | 46.74 | - | 2.24 | 18.00 | 17.32 | - |
| Earnings Per Share Diluted | 46.74 | - | 2.24 | 18.00 | 17.32 | - |
| Weighted Average Shares Outstanding | 2.93 Billion | 2.97 Billion | 2.99 Billion | 2.99 Billion | 2.99 Billion | 3.02 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.93 Billion | 2.97 Billion | 2.99 Billion | 2.99 Billion | 2.99 Billion | 3.02 Billion |
| Gross Margin | 0.24 | 0.22 | 0.16 | 0.14 | 0.12 | 0.15 |
| EBIT Margin | 0.13 | - | 0.08 | 0.11 | 0.12 | - |
| Profit Margin | 0.08 | 0.04 | 0.00 | 0.03 | 0.04 | 0.06 |
| EBITDA | 234.4 Billion | - | 142.81 Billion | 182.28 Billion | 175.29 Billion | - |
| Earnings Before Tax Margin | 0.08 | 0.05 | 0.01 | 0.06 | 0.04 | 0.06 |
INDRAMEDCO
CBE
NKRKF
PBSV
GAEL
ILU